Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu
Education
  • 2009 Uludağ University / Radyasyon Onkolojisi / Professor
  • 2002 Uludağ University / Radyasyon Onkolojisi / Associate Professor
  • 1991 Şişli Etfal Eğitim ve Araştırma Hospital Radyasyon Onkolojisi
  • 1985 Akdeniz University Faculty of Medicine
Experience
  • 2023 Acıbadem Healthcare Services
  • 2018 - 2023 Ceylan İnternatiaonal Hospital / Uzman Doktor
  • 2015 - 2018 Denizli Özel Sağlık Hospital / Uzman Dr.
  • 2009 - 2015 UÜTF Radyasyon Onkolojisi Department / Prof. Dr.
  • 2005 - 2009 UÜTF Radyasyon Onkolojisi Department / Doç. Dr.
  • 2004 - 2005 Denizli Onkomer Özel Onkoloji Merkezi / Uzman Dr.
  • 1996 - 2004 UÜTF Radyasyon Onkolojisi Department / Yar. Doç. Dr.
  • 2000 University of Kentucky / Fellow
  • 1995 - 1996 UÜTF Radyasyon Onkolojisi Department / Uzman Dr.
  • 1991 - 1995 SB Şişli Etfal Hospital, Radyasyon Onkolojisi / Chief Assistant
  • 1987 - 1991 SB Şişli Etfal Hospital, Radyasyon Onkolojisi / Araştırma Görevlisi
  • 1985 - 1987 Siirt Devlet Hospital (Zorunlu Hizmet) / Pratisyen Dr.
PUBLICATIONS
  • Carcinoma originating from aberrant breast tissue. A case report and review of the literature Tumori 94(3):440-3 (2008). Cetintas S.K., Turan-Ozdemir S, Topal U, Kurt M, Gokgoz S, Saraydaroglu O, Ozkan L.
  • Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer Hepatogastroenterology 55(85):1158-63 (2008). Kurt M, Ozkan L, Kurt E, Cetintas SK, Aygun S, Ercan I, Yilmazlar T, Memik F.
  • Successful spontaneous pregnancy in a patient with rectal carcinoma treated with pelvic radiotherapy and concurrent chemotherapy: the unique role of laparoscopic lateral ovary transposition Eur J Gyn Oncol 28 (5): 408-410 (2007). Kurt M, Uncu G, Cetintas SK, Kucuk N, Guler S, Ozkan L
  • Synchronous breast cancer in spouses Tumori 92 (3): 244-245 (2006). Cetintas S.K., Kurt M, Gokgoz S, Ozkan L, Engin K, Tasdelen I
  • Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer Tumori 92 (6): 481-486 (2006). Kurt E, Kurt M, Kanat O, Cetintas SK, Aygun S, Palazoglu J, Ozkan L, Evrensel T, Kaya E, Manavoglu O,
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""